A detailed history of All Terrain Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, All Terrain Financial Advisors, LLC holds 6,397 shares of AMGN stock, worth $2.02 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
6,397
Previous 6,304 1.48%
Holding current value
$2.02 Million
Previous $1.79 Million 11.5%
% of portfolio
0.84%
Previous 0.77%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $24,435 - $29,695
93 Added 1.48%
6,397 $2 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $806 - $973
-3 Reduced 0.05%
6,304 $1.79 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $14,319 - $16,153
56 Added 0.9%
6,307 $1.82 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $12,463 - $15,473
57 Added 0.92%
6,251 $1.68 Million
Q2 2023

Aug 04, 2023

BUY
$214.27 - $253.37 $117,419 - $138,846
548 Added 9.71%
6,194 $1.38 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $9,934 - $12,108
44 Added 0.79%
5,646 $1.36 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $17,864 - $22,698
78 Added 1.41%
5,602 $1.47 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $4,713 - $5,316
21 Added 0.38%
5,524 $1.25 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $94,591 - $105,263
-410 Reduced 6.93%
5,503 $1.34 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $49,335 - $54,578
-225 Reduced 3.67%
5,913 $1.43 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $795 - $910
-4 Reduced 0.07%
6,138 $1.38 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $6,580 - $7,709
-31 Reduced 0.5%
6,142 $1.31 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $42,044 - $46,645
-180 Reduced 2.83%
6,173 $1.51 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $13,314 - $15,516
60 Added 0.95%
6,353 $1.58 Million
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $82,008 - $97,656
379 Added 6.41%
6,293 $1.45 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $15,252 - $16,961
65 Added 1.11%
5,914 $1.5 Million
Q2 2020

Jul 28, 2020

SELL
$197.81 - $242.74 $36,594 - $44,906
-185 Reduced 3.07%
5,849 $1.38 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $2,004 - $2,658
-11 Reduced 0.18%
6,034 $1.22 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $10,028 - $12,889
-53 Reduced 0.87%
6,045 $1.46 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $68,947 - $82,613
-396 Reduced 6.1%
6,098 $1.18 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $833 - $977
5 Added 0.08%
6,494 $1.2 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $48,834 - $55,047
-270 Reduced 3.99%
6,489 $1.23 Million
Q4 2018

Feb 15, 2019

BUY
$178.4 - $208.25 $3,389 - $3,956
19 Added 0.28%
6,759 $1.32 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $1,111 - $1,253
-6 Reduced 0.09%
6,740 $1.4 Million
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $54,132 - $60,802
326 Added 5.08%
6,746 $1.25 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $26,261 - $30,690
155 Added 2.47%
6,420 $1.1 Million
Q4 2017

Feb 15, 2018

BUY
$168.79 - $188.59 $1.06 Million - $1.18 Million
6,265
6,265 $1.09 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track All Terrain Financial Advisors, LLC Portfolio

Follow All Terrain Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Terrain Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Terrain Financial Advisors, LLC with notifications on news.